DIVIS LABORATORIES
|
The Current P/B Ratio of DIVIS LABORATORIES is 11.00.
Share Price | ₹5,622.3 | Feb 01,2025 |
Market Cap | ₹149,272.1 Cr | |
Book Value | ₹13,571.0 Cr | Mar2024 - Consolidated Results |
Price/Book | 11.00x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of DIVIS LABORATORIES
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹149,272.1 Cr] as on Feb 01,2025
(/) Book Value [ ₹13,571.0 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 11.00x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '11.00 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/B Ratio of DIVIS LABORATORIES over the last five years.
Historical PB (Price/Book ) ratio chart of DIVIS LABORATORIES
PB Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.03x.
- DIVIS LABORATORIES 's operated at median p/b ratio of 7.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/b ratio peaked in Mar2021 at 10.37x.
- DIVIS LABORATORIES 's p/b ratio hit its five-year low in Mar2023 of 5.87x.
How does DIVIS LABORATORIES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
DIVIS LABORATORIES | 13,571.00 | 11.00 | 149,272.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.57 | 418,132.0 |
CIPLA LTD | 26,619.90 | 4.36 | 116,123.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.58 | 100,573.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.94 | 97,966.9 |
MANKIND PHARMA LTD | 9,339.84 | 10.96 | 102,348.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.82 | 108,477.0 |
LUPIN LTD | 14,175.80 | 6.62 | 93,813.7 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.22 | 66,385.6 |
ABBOTT INDIA LTD | 3,658.73 | 15.05 | 55,059.0 |
ALKEM LABORATORIES LTD | 10,292.50 | 5.84 | 60,079.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs DIVIS LABORATORIES 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.22x |
Max industry PB | 15.82x |
Median industry PB | 6.57x |
Average industry PB | 7.90x |
You may also like the below Video Courses